Thursday, November 15, 2018

ACEA Biosciences Acquired By Agilent For $250M

San Diego-based ACEA Biosciences, a developer of cell analysis tools, has been acquired by Agilent Technologies for $250M in cash. Agilent said it completed the acquisition late Wednesday. ACEA develops two platforms used for cellular function and metabolism measurements, used in immuno-oncology, pre-clinical

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.